Bridging the “Know-Do” Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation Science

Autor: Donohue JF, Elborn JS, Lansberg P, Javed A, Tesfaye S, Rugo H, Duddi SRD, Jithoo N, Huang PH, Subramaniam K, Ramanjinappa N, Koltun A, Melamed S, Chan JCN

Publikováno v: Journal of Healthcare Leadership, Vol Volume 15, Pp 103-119 (2023)

James F Donohue,1 J Stuart Elborn,2 Peter Lansberg,3 Afzal Javed,4 Solomon Tesfaye,5 Hope Rugo,6 Sita Ratna Devi Duddi,7,8 Niraksha Jithoo,9 Pai-Hui Huang,10 Kannan Subramaniam,11 Nagendra Ramanjinappa,12 Arkady Koltun,13 Shari Melamed,13 Juliana CN

Externí odkaz: https://doaj.org/article/7ab825fbd9ed487da58665c96ae48b1d

Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD

Autor: Donohue JF, Mahler DA, Sethi S

Publikováno v: International Journal of COPD, Vol Volume 14, Pp 2947-2958 (2019)

James F Donohue,1 Donald A Mahler,2,3 Sanjay Sethi4 1Pulmonary Medicine, UNC School of Medicine, Chapel Hill, NC, USA; 2Geisel School of Medicine at Dartmouth, Hanover, NH, USA; 3Director of Respiratory Services, Valley Regional Hospital, Claremont,

Externí odkaz: https://doaj.org/article/5ba64fd1fb764e7e9e11e8781503a53c

Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).

Autor: Parker CC; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: chris.parker@rmh.nhs.uk., Petersen PM; Department of Oncology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester; Manchester Cancer Research Centre, The University of Manchester, Manchester; Department of Urology, Salford Royal NHS Foundation Trust, Manchester, UK, Department of Urology, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Catton C; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Cross WR; Department of Urology, St James's University Hospital, Leeds., Kynaston H; Division of Cancer and Genetics, Cardiff University, Cardiff, UK., Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, Canada., Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK., Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada., Bower L; Guy's and St Thomas' NHS Foundation Trust, London; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, UK., Durkan GC; Department of Urology, University Hospital Galway, Galway, Ireland., Logue J; Department of Oncology, The Christie Hospital NHS FT, Wilmslow Road, Manchester., Maniatis C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Noor D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Payne H; The Prostate Centre, London., Anderson J; St James's Institute of Oncology, Leeds., Bahl AK; Bristol Haematology and Oncology Centre, University Hospitals Bristol & Weston NHS Trust, Bristol., Bashir F; Queen's Centre for Oncology, Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Cottingham, UK., Bottomley DM; St James's Institute of Oncology, Leeds., Brasso K; Department of Urology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Capaldi L; Worcester Oncology Centre, Worcestershire Acute NHS Hospitals Trust, Worcester., Chung C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Cooke PW; Department of Urology, The Royal Wolverhampton NHS Trust, Wolverhampton., Donohue JF; Department of Urology, Maidstone and Tunbridge Wells NHS Trust, Maidstone., Eddy B; East Kent University Hospitals Foundation Trust, Kent., Heath CM; Department of Clinical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton., Henderson A; Department of Urology, Maidstone and Tunbridge Wells NHS Trust, Maidstone., Henry A; Leeds Institute of Medical Research, University of Leeds, Leeds., Jaganathan R; Department of Urology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Jakobsen H; Department of Urology, Herlev University Hospital, Herlev, Denmark., James ND; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, UK., Joseph J; Leeds Teaching Hospitals; York and Scarborough Teaching Hospitals, York., Lees K; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Maidstone., Lester J; South West Wales Cancer Centre, Singleton Hospital, Swansea, UK., Lindberg H; Department of Oncology, Herlev University Hospital, Herlev, Denmark., Makar A; Department of Urology, Worcestershire Acute Hospitals Trust, Worcester., Morris SL; Guy's and St Thomas' NHS Foundation Trust, London., Oommen N; Wrexham Maelor Hospital, Wrexham., Ostler P; Department of Urology, Hillingdon Hospitals NHS Foundation Trust, Hillingdon, London., Owen L; Bradford Royal Infirmary, Bradford; Leeds Cancer Centre, Leeds., Patel P; Department of Urology, University College London Hospitals, London., Pope A; Department of Urology, Hillingdon Hospitals NHS Foundation Trust, Hillingdon, London., Popert R; Guy's and St Thomas' NHS Foundation Trust, London., Raman R; Kent Oncology Centre, Kent & Canterbury Hospital, Canterbury., Ramani V; Department of Urology, The Christie NHS Foundation Trust, Manchester., Røder A; Department of Urology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen., Sayers I; Deanesly Centre, New Cross Hospital, Wolverhampton., Simms M; Department of Urology, Hull University Hospitals NHS Trust, Hull., Srinivasan V; Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Rhyl., Sundaram S; Department of Urology, Mid Yorkshire Teaching Hospital, Wakefield., Tarver KL; Department of Oncology, Queen's Hospital, Romford., Tran A; Department of Oncology, The Christie Hospital NHS FT, Wilmslow Road, Manchester., Wells P; Barts Cancer Centre, St Bartholomews Hospital, London., Wilson J; Royal Gwent Hospital, Newport., Zarkar AM; Department of Oncology, University Hospitals Birmingham, Birmingham, UK., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London. Electronic address: mrcctu.radicals@ucl.ac.uk.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jul; Vol. 35 (7), pp. 656-666. Date of Electronic Publication: 2024 Apr 05.

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT

Autor: D'Urzo AD, Singh D, Donohue JF, Kerwin EM, Ribera A, Molins E, Chuecos F, Jarreta D, Garcia Gil E

Publikováno v: International Journal of COPD, Vol Volume 14, Pp 479-491 (2019)

Anthony D D’Urzo,1 Dave Singh,2 James F Donohue,3 Edward M Kerwin,4 Anna Ribera,5 Eduard Molins,5 Ferran Chuecos,5 Diana Jarreta,5 Esther Garcia Gil5 1Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto,

Externí odkaz: https://doaj.org/article/14967ec20d684940985c8acc51931b02

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.